RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Societal CDMO Stock

Societal CDMO Employees 2024

Societal CDMO Employees

185

Ticker

SCTL

ISIN

US75629F1093

WKN

A1XFAV

In 2024, Societal CDMO employed 185 people, a 0% change from the 185 number of employees in the previous year.

Societal CDMO Aktienanalyse

What does Societal CDMO do?

Recro Pharma Inc. is a company operating in the biopharmaceutical industry, specializing in the development and marketing of innovative therapeutics. The company is based in Malvern, Pennsylvania, USA, and was founded in 2007. The history of Recro Pharma Inc. dates back to 1985, when the company was founded as ReceptoPharm. In 2008, it was renamed Recro Pharma Inc. to emphasize its focus on pharmaceutical activities. Since then, the company has made significant progress, including successful clinical trials and the introduction of innovative products. Recro Pharma follows a business model based on the development of therapeutics in the areas of pain management and anesthesia. The company aims to create solutions to alleviate pain in patients and improve their quality of life. Recro Pharma's goal is to bring high-quality products to the market that are distinguished by excellent safety, efficacy, and patient tolerance. Recro Pharma's product range currently includes two main areas. Firstly, the company has launched its medication Meloxicam for pain treatment in adults. Secondly, it has developed and distributes a portfolio of anesthesia-related therapeutics through its subsidiary Lumendi LLC. Meloxicam is a non-steroidal anti-inflammatory drug used for pain relief in adults. The medication is available in various forms such as tablets and capsules and is used in both hospital and outpatient care. Lumendi LLC specializes in the development and distribution of anesthesia-related therapeutics. The company's products include those for intubation and muscle relaxation in surgical procedures, as well as anesthesia for pain management. Lumendi's goal is to create innovative solutions to improve medical practice and shorten hospital stays. Recro Pharma Inc. aims to expand its product range through the development of further innovative solutions. The company continues to invest in research and development to develop new products and strengthen its position in the market. In 2020, Recro Pharma Inc. received FDA approval for the product IV Meloxicam. This is an intravenous form of the drug Meloxicam used for pain treatment in adults. This is a significant milestone for the company as it is now able to offer an alternative form of the medication. Recro Pharma Inc. has established itself as a significant player in the biopharmaceutical industry. The company aspires to further strengthen its position in the market and create innovative solutions to improve medical practice. With its high-quality products, Recro Pharma contributes to alleviating patients' pain and improving their quality of life. Societal CDMO ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Societal CDMO's Employee Base

Societal CDMO's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Societal CDMO's operational capacity and future potential.

Year-to-Year Comparison

Assessing Societal CDMO's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Societal CDMO's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Societal CDMO’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Societal CDMO stock

How many employees does Societal CDMO have this year?

Societal CDMO has 185 undefined employees this year.

How many employees did Societal CDMO have compared to the previous year?

Compared to the previous year, Societal CDMO had 0% more employees.

What impact did the number of employees have on the company Societal CDMO?

The number of employees has a direct impact on the efficiency and productivity of Societal CDMO. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Societal CDMO?

The number of employees can also have an impact on investors of Societal CDMO, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Societal CDMO affect the company?

An increase in equity of Societal CDMO can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Societal CDMO's equity affect the company?

A reduction in equity of Societal CDMO can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Societal CDMO?

Some factors that can influence the equity of Societal CDMO include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Societal CDMO so important for investors?

The equity of Societal CDMO is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Societal CDMO influence the company?

The number of employees at Societal CDMO can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Societal CDMO evolved in recent years?

In recent years, the number of employees at Societal CDMO has changed by 0.

How many employees does Societal CDMO currently have?

Societal CDMO currently has 185 undefined employees.

Why is the number of employees important for investors of Societal CDMO?

The number of employees is important for investors of Societal CDMO as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Societal CDMO take to change the number of employees?

To change the number of employees, Societal CDMO can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Societal CDMO pay?

Over the past 12 months, Societal CDMO paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Societal CDMO is expected to pay a dividend of 0 USD.

What is the dividend yield of Societal CDMO?

The current dividend yield of Societal CDMO is .

When does Societal CDMO pay dividends?

Societal CDMO pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Societal CDMO?

Societal CDMO paid dividends every year for the past 0 years.

What is the dividend of Societal CDMO?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Societal CDMO located?

Societal CDMO is assigned to the 'Health' sector.

Wann musste ich die Aktien von Societal CDMO kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Societal CDMO from 8/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/10/2024.

When did Societal CDMO pay the last dividend?

The last dividend was paid out on 8/10/2024.

What was the dividend of Societal CDMO in the year 2023?

In the year 2023, Societal CDMO distributed 0 USD as dividends.

In which currency does Societal CDMO pay out the dividend?

The dividends of Societal CDMO are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Societal CDMO

Our stock analysis for Societal CDMO Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Societal CDMO Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.